Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133406) titled 'Isolation and Identification of Brain-Derived Disease-Specific a-Synuclein in the Blood of Parkinson's Patients' on Sept. 25.
Study Type: Diagnostic test
Study Design:
Case-Control study
Primary Sponsor: Army Medical Center of PLA
Condition:
Parkinson's disease, neurodegenerative diseases, Alzheimers disease, and so on
Intervention:
Gold Standard:Clinical diagnostic gold standard: assessment by senior movement disorder experts, following the MDS-PD criteria.
Pathological gold standard: Lewy bodies found at autopsy.
Emerging biological gold standard: a-synuclein seed amplification testing.
Recruitment S...